Skip to content

Research paper

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

The New England journal of medicine
Q1
Oct 2015
Citations: 283
Influential: 10
Interventional (Human) Studies
98

Study answer

What this study found

Daily vitamin D3, calcium, or both did not significantly reduce recurrent colorectal adenomas or advanced adenomas in this population. For any adenoma, the adjusted risk ratio was 0.99 (95% CI, 0.89 to 1.09) for vitamin D versus no vitamin D and 0.95 (95% CI, 0.85 to 1.06) for calcium versus no calcium. Vitamin D plus calcium also showed no benefit versus calcium alone (risk ratio, 1.01; 95% CI, 0.88 to 1.15) or versus neither agent (risk ratio, 0.93; 95% CI, 0.80 to 1.08). Contingency-table comparisons were likewise nonsignificant: P = 0.98, P = 0.37, P = 0.79, and P = 0.49, respectively.…

Study & population
This was a randomized multicenter trial conducted at 11 academic medical centers and associated practices in the United States.
Intervention
Participants took oral vitamin D3 1000 IU daily, calcium carbonate 1200 mg daily, both agents together, or matched comparators in a 2-by-2 factorial regimen.
Key limitation
The vitamin D dose was relatively modest, which may have limited efficacy detection.
View sourceOpen PDF

Original abstract

No abstract is available for this paper.